Cargando…
Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review
Clinical research in high-income countries is increasingly demonstrating the cost- effectiveness of clinical pharmacogenetic (PGx) testing in reducing the incidence of adverse drug reactions and improving overall patient care. Medications are prescribed based on an individual’s genotype (pharmacogen...
Autores principales: | B. Tata, Emiliene, A. Ambele, Melvin, S. Pepper, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560181/ https://www.ncbi.nlm.nih.gov/pubmed/32858798 http://dx.doi.org/10.3390/pharmaceutics12090809 |
Ejemplares similares
-
Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective
por: Nthontho, Keneuoe Cecilia, et al.
Publicado: (2022) -
Pharmacogenomics for infectious diseases in sub-Saharan Africa: Successes and opportunities
por: Chaudhry, Mamoonah, et al.
Publicado: (2016) -
Barriers to childhood immunization in sub-Saharan Africa: A systematic review
por: Bangura, Joseph Benjamin, et al.
Publicado: (2020) -
Barriers and facilitators to implementing bubble CPAP to improve neonatal health in sub-Saharan Africa: a systematic review
por: Kinshella, Mai-Lei Woo, et al.
Publicado: (2020) -
Implementation Approaches for Introducing and Overcoming Barriers to Hepatitis B Birth-Dose Vaccine in sub-Saharan Africa
por: Boisson, Alix, et al.
Publicado: (2022)